Amneal Pharmaceuticals Non-GAAP EPS of $0.21 beats by $0.03, revenue of $814M beats by $6.68M
Source: SeekingAlpha
2026-02-27 06:09:01 ET
More on Amneal Pharmaceuticals
- Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Amneal Pharmaceuticals, Inc. (AMRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Amneal: Growing Drug Portfolio, Positive Cash Flow, Outweighing Leverage Risks
- Amneal Pharmaceuticals Q4 2025 Earnings Preview
- Amneal initiates nationwide settlement for opioid-related claims
Read the full article on Seeking Alpha
For further details see:
Amneal Pharmaceuticals Non-GAAP EPS of $0.21 beats by $0.03, revenue of $814M beats by $6.68M
Amneal Pharmaceuticals Inc. Class A
NASDAQ: AMRX
AMRX Trading
3.69% G/L:
$13.505 Last:
615,861 Volume:
$13.21 Open:
AMRX Latest News
AMRX Stock Data
$4,628,993,997
156,741,352
0.09%
93
N/A
Pharmaceuticals
Healthcare
US
Bridgewater
